Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Lupus. 2018 Feb 16;27(7):1065–1071. doi: 10.1177/0961203318759428

Table 3.

Additional Treatments for MAS Administered In Hospital

Medications %
IV steroids 47.8
Intravenous Immunoglobulin 17.4
Cyclophosphamide 13.0
Rituximab 8.7
Cyclosporine 8.7
Anakinra 8.7
Etoposide 8.7
Allogeneic BMT 8.7
Mycophenolate mofetil 8.7
Hydroxychloroquine 8.7
Alemtuzumab 4.3